uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Zoledronic acid Teva
Authorised
Human
Details
EMA number
EMEA/H/C/002439
ATC code
M05BA08
Authorisation
16 August 2012
Revision
16
EMA page
Therapeutic indication
Prevention of skeletal-related events and treatment of tumour-induced hypercalcaemia.
MeSH:
Fractures, Bone;Cancer
Group:
Drugs for treatment of bone diseases
Active substances
zoledronic acid
Marketing Authorisation Holder
Teva B.V
MAH
Timeline
Filter by authority:
EMA
Zoledronic acid Teva authorised
16 Aug 2012
authorised
regulatory
Zoledronic acid Teva | uMedical